Enanta Pharmaceuticals (ENTA) Stock Highlights

11.39 | -2.23%

2024-09-19 05:06:59

Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The companys inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Statistics

Range Today

11.26 11.85

Volume Today 134.5K

Range 1 Year

8.08 17.8

Volume 1 Year 58.56M

Range 3 Year

8.08 102

Volume 3 Year 174.25M

Range 10 Year

8.08 127.77

Volume 10 Year 588.23M

Highlights

Market Capitalization 263.37M (small)

Floating Shares 15.44M

Current Price 11.39

Price To Earnings -2.27

Price To Revenue 3.54

Price To Book 1.77

Earnings Per Share -5.45

Payout Ratio 0%

Performance

Latest -2.23%

1 Month -6.64%

3 Months -4.92%

6 Months -21.34%

1 Year -11.71%

3 Years -80.2%

5 Years -83.62%

10 Years -71.61%

Benchmarks

Market Capitalization

203 / 368

Gross Profits

49 / 278

Total Revenue

99 / 300

Total Rank

115 / 368

Free Cashflow

159 / 352

Performance 5 years

255 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.